Favorable clinical safety, pharmacokinetics and anti-CMV activity reported for 1263W94 Feb. 5, 1998 No Comments
Glaxo Wellcome characterizes in vitro/in vivo antibacterial activity of new trinem Feb. 4, 1998 No Comments